AAAAAA

   
Results: 1-10 |
Results: 10
Effect of sirolimus on the metabolism of ApoB100-containing lipoproteins in renal transplant patients
Authors: Hoogeveen, RC Ballantyne, CM Pownall, HJ Opekun, AR Hachey, DL Jaffe, JS Oppermann, S Kahan, BD Morrisett, JD
Citation: Rc. Hoogeveen et al., Effect of sirolimus on the metabolism of ApoB100-containing lipoproteins in renal transplant patients, TRANSPLANT, 72(7), 2001, pp. 1244-1250
Helicobacter pylori infection in children of Texas
Authors: Opekun, AR Gilger, MA Denyes, SM Nirken, MH Philip, SP Osato, MS Malaty, HM Hicks, J Graham, DY
Citation: Ar. Opekun et al., Helicobacter pylori infection in children of Texas, J PED GASTR, 31(4), 2000, pp. 405-410
Efficacy of ursodeoxycholic acid in the treatment of primary sclerosing cholangitis in children
Authors: Gilger, MA Gann, ME Opekun, AR Gleason, WA
Citation: Ma. Gilger et al., Efficacy of ursodeoxycholic acid in the treatment of primary sclerosing cholangitis in children, J PED GASTR, 31(2), 2000, pp. 136-141
Metronidazole containing quadruple therapy for infection with metronidazole resistant Helicobacter pylori: a prospective study
Authors: Graham, DY Osato, MS Hoffman, J Opekun, AR Anderson, SY Kwon, DH El-Zimaity, HMT
Citation: Dy. Graham et al., Metronidazole containing quadruple therapy for infection with metronidazole resistant Helicobacter pylori: a prospective study, ALIM PHARM, 14(6), 2000, pp. 745-750
Furazolidone combination therapies for Helicobacter pylori infection in the United States
Authors: Graham, DY Osato, MS Hoffman, J Opekun, AR Anderson, SY El-Zimaity, HMT
Citation: Dy. Graham et al., Furazolidone combination therapies for Helicobacter pylori infection in the United States, ALIM PHARM, 14(2), 2000, pp. 211-215
Norwalk virus vaccines: Challenges and progress
Authors: Estes, MK Ball, JM Guerrero, RA Opekun, AR Gilger, MA Pacheco, SS Graham, DY
Citation: Mk. Estes et al., Norwalk virus vaccines: Challenges and progress, J INFEC DIS, 181, 2000, pp. S367-S373
Novel therapies for Helicobacter pylori infection
Authors: Opekun, AR El-Zaimaity, HMT Osato, MS Gilger, MA Malaty, HM Terry, M Headon, DR Graham, DY
Citation: Ar. Opekun et al., Novel therapies for Helicobacter pylori infection, ALIM PHARM, 13(1), 1999, pp. 35-41
Evidence of SV40 infections in hospitalized children
Authors: Butel, JS Jafar, S Wong, C Arrington, AS Opekun, AR Finegold, MJ Adam, E
Citation: Js. Butel et al., Evidence of SV40 infections in hospitalized children, HUMAN PATH, 30(12), 1999, pp. 1496-1502
Helicobacter pylori and abdominal symptoms
Authors: Gilger, MA Opekun, AR
Citation: Ma. Gilger et Ar. Opekun, Helicobacter pylori and abdominal symptoms, PEDIATRICS, 103(1), 1999, pp. 192-192
Recombinant Norwalk virus-like particles given orally to volunteers: PhaseI study
Authors: Ball, JM Graham, DY Opekun, AR Gilger, MA Guerrero, RA Estes, MK
Citation: Jm. Ball et al., Recombinant Norwalk virus-like particles given orally to volunteers: PhaseI study, GASTROENTY, 117(1), 1999, pp. 40-48
Risultati: 1-10 |